Haemonetics (HAE) in Pivotal Point Check: Return of Major Customer and Q1 Numbers Trigger 16% Stock Jump in Medical Technology Stock!

Comeback with a Major Customer: CSL Plasma will now use the NexSys-PCS devices with Persona-PLUS technology in the USA. Validation of the Platform: The return of the previously lost customer underscores Haemonetics' technological strength. Strong Financial Foundation: Convincing Q1 quarterly results and an increased annual forecast provided momentum in advance. Haemonetics, a provider of medical technology and systems for blood and plasma management, caused a significant stock jump with high volume on August 18. The stock rose nearly...